key: cord-0739874-a8z6e61m authors: İpek, Sevcan; Güllü, Ufuk Utku; Yurttutan, Sadık; Güngör, Şükrü; Yurttutan, Nursel title: MIS-C with diarrhea complaint and acute kidney injury: A pediatric COVID-19 patient date: 2021-09-15 journal: Prog Pediatr Cardiol DOI: 10.1016/j.ppedcard.2021.101436 sha: 7ffb5adcfe1914c4ab432d671869ec3feace5348 doc_id: 739874 cord_uid: a8z6e61m We present the case of a 3-month-old male infant patient who initially presented with severe dehydration with acute kidney injury secondary to COVID-19. Regarding the individual's previous history, the patient had congenital heart disease and was taking furosemide and captopril. The patient improved after initial hydration therapy. However, on the fourth day of hospitalization, the patient suddenly deteriorated and was found to have MIS-C. The patient's clinical course progressively worsened despite maximum support, and he died from severe MIS-C. We conclude that during the COVID-19 period, MIS-C is a serious health problem that should be considered in the differential diagnosis of patients with acute kidney injury. Multisystem inflammatory syndrome (MIS-C) associated with COVID-19 in children is defined as the presence of fever, inflammation, and organ dysfunction after excluding microbial causes (1). Gastrointestinal symptoms such as diarrhea, nausea/vomiting, abdominal pain and renal dysfunction have been reported in pediatric patients with COVID-19 (2, 3) . In this article, we present a 3-month-old patient diagnosed with congenital heart disease who was referred to our hospital with acute kidney injury (AKI) secondary to diarrhea due to COVID-19 and was then diagnosed with MIS-C. A 3-month-old male patient with chronic heart failure secondary to a large ventricular septal defect (VSD) and atrial septal defect (ASD) who was being treated with captopril and furosemide was referred to our department with a diagnosis of AKI due to the absence of urine output and decreased nutrition. The mother said that he had fever and diarrhea for 3 days and that she had continued to give him his home captopril and furosemide medications. On examination, the patient had a body weight of 4.4 kg, his mucosa was dry, his capillary refilling time was long, he was in a confused state, his anterior fontanel was sunken, and he was tachycardic (196/min) and hypotensive (60/32 mmHg) and had reduced turgor tone. The patient's creatinine was 5.76 mg/dL, his BUN was 46 mg/dL, and his uric acid was 18.6 mg/dL. At admission, his CRP was 2.98 mg/L, his procalcitonin was 0.48 µg/L, his WBC was 9,960/mm 3 Table 1 . Upon follow-up, the patient's electrocardiograms showed sinus tachycardia, nonspecific ST segment and T wave changes, long QTC distance (0.46), and a first-degree atrioventricular block. He had a fever at the time of admission and improved during follow-up, but his fever relapsed. In addition, the patient had cardiac, respiratory, renal and hematological involvement. While the patient's condition improved, after this sudden decompensation and possible sepsis were excluded, a diagnosis of multisystem inflammatory syndrome (MIS-C) was made according to the CDC criteria based on the clinical history and trajectory. The patient was started on MIS-C treatment consisting of pulse-dose steroids and intravenous immunoglobulin. Despite vasoactive drug Gastrointestinal manifestations of pediatric coronavirus disease and their relationship with a severe clinical course: A systematic review and meta-analysis Renal dysfunction in hospitalised children with COVID-19. The Lancet Child & adolescent health Inflammasome activation at the crux of severe COVID-19 Coronavirus Disease 2019 (COVID-19) Pandemic Implications in Pediatric and Adult Congenital Heart Disease Acute myocarditis and multisystem inflammatory emerging disease following SARS-CoV-2 infection in critically ill children